Patents by Inventor Benoit Gourdet

Benoit Gourdet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20230167111
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: December 9, 2022
    Publication date: June 1, 2023
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 11560379
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: January 24, 2023
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • ADO-resistant cysteamine analogs and uses thereof
    Patent number: 11505550
    Abstract: The present disclosure is directed to methods for treating diseases for which cysteamine is indicated and compounds useful in such methods.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: November 22, 2022
    Assignee: HORIZON ORPHAN LLC
    Inventors: Todd C. Zankel, John Unitt, Timothy Phillips, Benoit Gourdet, Lorna Duffy
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 11370789
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: June 28, 2022
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF
    Publication number: 20220024920
    Abstract: The present disclosure is directed to methods for treating diseases for which cysteamine is indicated and compounds useful in such methods.
    Type: Application
    Filed: February 1, 2021
    Publication date: January 27, 2022
    Inventors: Todd C. Zankel, John Unitt, Timothy Phillips, Benoit Gourdet, Lorna Duffy
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20210139478
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 13, 2021
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • ADO-resistant cysteamine analogs and uses thereof
    Patent number: 10906904
    Abstract: The present disclosure is directed to methods for treating diseases for which cysteamine is indicated and compounds useful in such methods.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: February 2, 2021
    Assignee: HORIZON ORPHAN LLC
    Inventors: Todd C. Zankel, John Unitt, Timothy Phillips, Benoit Gourdet, Lorna Duffy
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20200361935
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 19, 2020
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 10787449
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: September 29, 2020
    Assignee: CORCEPT THERAPEUTICS, INC.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20190241563
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 8, 2019
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 10323034
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: June 18, 2019
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20190135805
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: July 16, 2018
    Publication date: May 9, 2019
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20190048004
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: October 16, 2018
    Publication date: February 14, 2019
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 10047082
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: August 14, 2018
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF
    Publication number: 20170002004
    Abstract: The present disclosure is directed to methods for treating diseases for which cysteamine is indicated and compounds useful in such methods.
    Type: Application
    Filed: July 5, 2016
    Publication date: January 5, 2017
    Applicant: RAPTOR PHARMACEUTICALS INC.
    Inventors: Todd C. Zankel, John Unitt, Timothy Phillips, Benoit Gourdet, Lorna Duffy
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20150148341
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 28, 2015
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet